Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000894542 | SCV001038530 | likely benign | not provided | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001329477 | SCV001520930 | uncertain significance | Myopathy, centronuclear, 5 | 2020-01-14 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Ambry Genetics | RCV002539428 | SCV003690246 | uncertain significance | Inborn genetic diseases | 2022-06-13 | criteria provided, single submitter | clinical testing | The c.206C>T (p.T69M) alteration is located in exon 1 (coding exon 1) of the SPEG gene. This alteration results from a C to T substitution at nucleotide position 206, causing the threonine (T) at amino acid position 69 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV001329477 | SCV003820008 | uncertain significance | Myopathy, centronuclear, 5 | 2022-05-05 | criteria provided, single submitter | clinical testing |